Chapter 1.POC MOLECULAR DIAGNOSTICS MARKET    – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.POC MOLECULAR DIAGNOSTICS MARKET    – Executive Summary

2.1. Market Size & Forecast – (2022 – 2026) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-16 Impact Analysis

      2.3.1. Impact during 2022 - 2026

      2.3.2. Impact on Supply – Demand

Chapter 3.POC MOLECULAR DIAGNOSTICS MARKET    – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.POC MOLECULAR DIAGNOSTICS MARKET    - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. POC MOLECULAR DIAGNOSTICS MARKET   - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2.  Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6.POC MOLECULAR DIAGNOSTICS MARKET    – By PRODUCT

6.1. Instruments

6.2. Reagents

6.3. Others

Chapter 7.POC MOLECULAR DIAGNOSTICS MARKET   – By TEST LOCATION

7.1.  Point-of-Care

7.2. Self-test or Over the Counter

7.3. Central Laboratories

Chapter 8 .POC MOLECULAR DIAGNOSTICS MARKET   – By APPLICATION

8.1. Infectious Diseases

8.2. Oncology

8.3. Hematology

8.4. Prenatal Testing

8.5. Endocrinology

8.6. Other

Chapter 9.POC MOLECULAR DIAGNOSTICS MARKET   – By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. The Middle East

9.6. Africa

Chapter 10. POC MOLECULAR DIAGNOSTICS MARKET  – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. BD

10.2. bioMérieux SA

10.3. Bio-Rad Laboratories, Inc.

10.4. Abbott

10.5. Agilent Technologies, Inc.

10.6. Danaher

10.7. Hologic Inc. (Gen Probe)

10.9. Illumina, Inc.

10.9. Johnson & Johnson Services, Inc.

10.10. Grifols, S.A.

10.11. QIAGEN

10.12. F. Hoffmann-La Roche, Ltd.

10.13. Siemens Healthineers AG

10.14. Sysmex Corporation